Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

M. E. Cianfrocca; W. J. Gradishar

doi:10.1016/S1043-321X(06)80466-2

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

M. E. Cianfrocca, W. J. Gradishar

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	188
Number of pages	1
Journal	Breast Diseases
Volume	17
Issue number	2
DOIs	https://doi.org/10.1016/S1043-321X(06)80466-2
State	Published - Jul 2006

ASJC Scopus subject areas

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1043-321X(06)80466-2

Cite this

@article{af05884dee3642a6a9f6ba37853fa874,

title = "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer",

author = "Cianfrocca, {M. E.} and Gradishar, {W. J.}",

year = "2006",

month = jul,

doi = "10.1016/S1043-321X(06)80466-2",

language = "English (US)",

volume = "17",

pages = "188",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

AU - Cianfrocca, M. E.

AU - Gradishar, W. J.

PY - 2006/7

Y1 - 2006/7

UR - http://www.scopus.com/inward/record.url?scp=33745487173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745487173&partnerID=8YFLogxK

U2 - 10.1016/S1043-321X(06)80466-2

DO - 10.1016/S1043-321X(06)80466-2

M3 - Article

AN - SCOPUS:33745487173

SN - 1043-321X

VL - 17

SP - 188

JO - Breast Diseases

JF - Breast Diseases

IS - 2

ER -

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this